Component information
No US or EU label exists for this exact combination, so information is shown for each component.
- Hyoscine-n-butylbromide listed as hyoscine butylbromide
Use: Gastrointestinal and genitourinary spasm (tablets) renalcarematters.com, reviewed
Kidney dosing: Hyoscine-n-butylbromide (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- Tablets: 10 to 20 mg per dose, maximum 60 mg/day. Injection: 10 to 20 mg slowly IV, IM or SC, maximum 100 mg/day (PM).
- CrCl 30–59 mL/min
- The prescribing information gives no kidney dosing. Tablets: negligible absorption, kidney accumulation unlikely. Injection: about half of an intravenous dose is excreted unchanged in urine; use the lowest dose and watch for anticholinergic effects.
- CrCl 15–29 mL/min
- The prescribing information gives no kidney dosing. Tablets: negligible absorption, kidney accumulation unlikely. Injection: about half of an intravenous dose is excreted unchanged in urine; use the lowest dose and watch for anticholinergic effects.
- CrCl <15 mL/min (not on dialysis)
- The prescribing information gives no kidney dosing. Tablets: negligible absorption, kidney accumulation unlikely. Injection: about half of an intravenous dose is excreted unchanged in urine; use the lowest dose and watch for anticholinergic effects.
- Hemodialysis (intermittent)
- Not studied in dialysis; no dose given.
- Peritoneal dialysis
- Not studied in dialysis; no dose given.
- CRRT
- Not studied in dialysis; no dose given.
- Dialyzable? Not stated.
- Monitoring Anticholinergic effects: urinary retention, tachycardia, hypotension after injection (observe; emergency equipment available), raised intraocular pressure (urgent review for painful red eye). Avoid IM injection in anticoagulated patients (PM).
From the Hyoscine-n-butylbromide monograph (renalcarematters.com, reviewed).
Use: Uses temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 500 mg/10 mg
- Tablet: 10 mg/500 mg
Registered products in the Philippines
3 products registered with the Food and Drug Administration (FDA) Philippines list Hyoscine butylbromide + Paracetamol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products3
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
DysmenosParacetamol + Hyoscine Butylbromide | 500 mg / 10 mg Film-coated tabletAlu/PVC Blister pack x 10's (Box of 100's) | OTC | Saga Lifesciences LimitedIndia | Hexagon Pharmaceuticals | DR-XY46713 | Sep 19, 2029 | |
Hyopan PlusHyoscine butylbromide + Paracetamol | 10 mg/500 mg TabletAlu/Alu Foil Strip x 10's (Box of 30's and 100's) | OTC | Fredun Pharmaceuticals LimitedIndia | AMB HK Enterprises Inc. | DRP-14830 | Jan 17, 2029 | |
NavelinParacetamol + Hyoscine Butylbromide | 500 mg / 10 mg Film-Coated tabletAlu/PVC Blister Pack x 10's Box of 100's | OTC | Saga Lifesciences LimitedIndia | Hexagon Pharmaceuticals | DR-XY46716 | Sep 19, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .